List view / Grid view
Michael Merges, Director of Biopharmaceutical Support Services, and Michael Sadick, Ph.D., Senior Manager of Biopharmaceutical Characterization, Development and Analytical Services, Catalent Pharma Solutions, will be presenting “Bioassay Development Basics 101,” at the Biological Assay Development, Validation & Maintenance Conference in Boston, MA on Monday, April 30, 2012, at 1:30 p.m.
27 April 2012 | By Merck
"The court appropriately ruled that the patent for ZETIA and VYTORIN in the U.S. is valid..."
27 April 2012 | By Novo Nordisk
Sten Scheibye has been elected to the Board of the Novo Nordisk Foundation...
27 April 2012 | By GlaxoSmithKline
The European Commission has granted marketing authorisation for Nimenrix...
26 April 2012 | By Novartis
The FDA has approved Afinitor® tablets...
26 April 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved Votrient® (pazopanib)...
26 April 2012 | By Phenomenex Inc
Phenomenex Inc., introduces the “Kinetex Experience”...
26 April 2012 | By Novartis
Novartis associates to dedicate 200,000 work hours to supporting the local community...
26 April 2012 | By GlaxoSmithKline
Innovative carbon neutral laboratory to be established on University Campus...
26 April 2012 | By Tecan
The annual Tecan Symposium will be held in the US for the first time this year...
26 April 2012 | By AstraZeneca
AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire...
26 April 2012 | By Amgen
The FDA cannot approve the application in its present form...
25 April 2012 | By Eli Lilly and Company
Eli Lilly and Company has been named to the 2012 DiversityInc Top 50 Companies for Diversity list...
25 April 2012 | By AstraZeneca
AstraZeneca and The Medicines Company announced a global collaboration...
25 April 2012 | By Novartis
Novartis announced that the European Commission has approved Signifor®...
